“Company”) submitted its separate financial statement and its consolidated financial statement for the second quarter of 2018 and 6 months ended on 30 June 2018 which were reviewed by the auditor. The
Limited (the “Company”) submitted its separate financial statement and its consolidated financial statement for the third quarter of 2018 and 9 months ended on 30 September 2018 which were reviewed by the
Baht) Consolidated Financial Statements 3Q'19 3Q'18 % YTD YTD % Change 2019 2018 Change Total Revenue 452.8 443.4 2.1% 1,387.3 1,288.9 7.6% - Utilities Business 449.8 442.3 1.7% 1,381.4 1,287.0 7.3
subsidiaries as details below: (Unit: Baht millions) For the year ended 31st March Consolidated financial statement Apr 2019 - Mar 2020 Apr 2018 - Mar 2019 Change % Change Revenue from sales & service 2,756.44
“Company”) submitted its separate financial statement and its consolidated financial statement for the second quarter of 2020 ended on 30 June 2020 which were reviewed by the auditor. The Company hereby
OPERATION (Unit : Million Baht) Consolidated Financial Statements 2019 2018 % Change Total Revenue 1,857.2 1,708.3 8.7% - Utilities Business 1,847.1 1,705.1 8.3% - Operating Revenue1 1,734.3 1,679.7 3.3
of Modern (Closing Date) within 31st August 2020. 2. Parties Involved and Their Relationships with the Company: Buyer: Inter Pharma Public Company Limited (“the Company) Seller: Mr. Thongplew
/ Independent Director and Audit Committee 11. Mr. Devarajen Moorooven / Director 12. Mr. Benoît René Mignard / Director 4.3 Summary of the financial information of GLOW for 2015-2018 Consolidated Profit and Loss
Public Company Limited (Mr. Toemchai Bunnag) President and Chief Executive Officer Investor Relations Division Tel. 02-140-4628, 02-140-4630, 02-140-4691, 02-140-5318, 02-140-4715 Fax. 02-140-4601